Biotech

Startups News

Biotech Startups Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech

Top news of the week: 09.02.2022.

#biotech
#STTR
#GoodDayBIO
#CancerMoonshot
#SBIR
#NBTintheNews

Startups

@BentheFidler shared
On Feb 7, 2022
RT @NedPagliarulo: With link to @BentheFidler's deep dive on the current climate for biotech startups and their (narrowing) path to IPO: https://t.co/rcErDObjil https://t.co/7YKS33mVPb
Open
'The music stopped': Biotech rout leaves drug startups grounded as demand slumps for IPOs

'The music stopped': Biotech rout leaves drug startups grounded as demand slumps for IPOs

For the first time in years, biotechs no longer have an easy path onto Wall Street, a market reversal that could change what the next generation of young drugmakers looks like.

@FierceBiotech shared
On Feb 7, 2022
SPACs falter in a larger battering of biotech stocks, @ky_lahucik reports. https://t.co/utOAmPw9tP
Open
'Not afraid of not transacting': SPAC appetite sharply declines in larger battering of biotech stocks

'Not afraid of not transacting': SPAC appetite sharply declines in larger battering of biotech stocks

Fewer biotechs are merging with special purpose acquisition companies as drug developers get more "realistic and pragmatic" about the market.

@BentheFidler shared
On Feb 8, 2022
Al Sandrock, former top Biogen scientist, to join drug discovery startup's board https://t.co/71GgfVLWDu by @NedPagliarulo $BIIB $VYGR @VergeGenomics
Open
Al Sandrock, former top Biogen scientist, to join drug discovery startup's board

Al Sandrock, former top Biogen scientist, to join drug discovery startup's board

Sandrock's appointment to Verge Genomics' board of directors follows about a week after the executive took up a similar post with Voyager Therapeutics.

@FierceBiotech shared
On Feb 4, 2022
Arcellx bets on IPO despite market headwinds as it raises $124M to test a CAR-T BCMA therapy for patients with multiple myeloma in a pivotal trial. https://t.co/pxfDuAbA9p
Open
Arcellx raises $124M in Wall Street debut to bankroll study of multiple myeloma CAR-T

Arcellx raises $124M in Wall Street debut to bankroll study of multiple myeloma CAR-T

Cell therapy biotech Arcellx raised $124 million in its Wall Street debut, at the low end of its proposed range, to bankroll a phase 2 CAR-T BCMA therapy trial in patients with multiple ...

@matthewherper shared
On Feb 7, 2022
STAT to launch inaugural STATUS List, with leaders and influencers selected by expert panel https://t.co/sw7t7RdaqJ
Open
STAT to launch inaugural STATUS List, with leaders and influencers selected by expert panel

STAT to launch inaugural STATUS List, with leaders and influencers selected by expert panel

STAT to launch inaugural STATUS List, with leaders and influencers selected by expert panel

@IAmBiotech shared
On Feb 3, 2022
#GoodDayBIO: https://t.co/9HkvN6srBI Updates on President Biden’s #CancerMoonshot, the possible extension of #SBIR/#STTR, and why National Women Physicians Day (today!) matters. https://t.co/9HkvN6srBI
Open
Good Day BIO: Why the ‘Cancer Moonshot’ might never take off

Good Day BIO: Why the ‘Cancer Moonshot’ might never take off

Busy Thursday, with updates on President Biden’s Cancer Moonshot, the possible extension of SBIR/STTR, and why National Women Physicians Day (today!) matters. (828 words, 4 minutes, 8 ...

@FierceBiotech shared
On Feb 4, 2022
This week's Chutes & Ladders: @pfizer deals blow to @Roche leadership team. Bourdon's path from a meme stock to a Danish dermatology biopharma. And Sio CEO exits as program culled. https://t.co/fNnU7opxLo
Open
Chutes & Ladders—Pfizer poaches Roche's early R&D leader Pao to replace development chief

Chutes & Ladders—Pfizer poaches Roche's early R&D leader Pao to replace development chief

Pfizer picks from Roche's executive team, snagging pharma early R&D leader William Pao as the Big Pharma's next chief development officer. Leo Pharma poaches from ... a Danish meme stock ...

@NatureBiotech shared
On Feb 9, 2022
@GenomeInABottle @BCM_HGSC @dnanexus @PacBio @DanaFarber @NCBI @ResearchCM @RocheSequencing @uwgenome @sedlazeck @NIST New benchmark report from NIST, Baylor College of Medicine and DNAnexus helps provide accurate identification of variants in challenging medically relevant genes #NBTintheNews https://t.co/itLdg6TX7D
Open
New Benchmark Report from NIST, Baylor College of Medicine and DNAnexus Helps Provide Accurate Identification of Variants in Challenging Medically Relevant Genes

New Benchmark Report from NIST, Baylor College of Medicine and DNAnexus Helps Provide Accurate Identification of Variants in Challenging Medically Relevant Genes

New Nature Biotechnology publication features a comprehensive benchmark dataset comprising 273 challenging medically relevant autosomal genes

Read more: Startups
weekly 09.02.2022
View archives
Back to home

Subscribe to Biotech - Startups.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech - Startups.
Privacy Policy

Sign up for the weekly Biotech - Startups newsletter

Never again miss anything or anyone that matter in Biotech

Sign up and receive the Biotech - Startups weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy